EdgarLookup

Oruka Therapeutics, Inc. — All Filings

1,000 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-K405 10-Q 10-Q/A 144 3 3/A 4 4/A 424B2 424B3 424B4 424B5 425 5 8-A12G 8-K 8-K/A ARS CORRESP CT ORDER D DEF 14A DEFA14A EFFECT POS AM PRE 14A PRER14A RW S-1 S-1/A S-1MEF S-3 S-3/A S-3ASR S-3MEF S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-K ABIO-FORM 8-K YEAR END RESULTS 0001564590-17-004905 Mar 21, 2017
8-K ABIO-FORM 8-K TRIAL UPDATE 0001564590-17-003477 Mar 6, 2017
4 FORM 4 SUBMISSION 0001209191-17-015990 Mar 1, 2017 Feb 27, 2017
4 FORM 4 SUBMISSION 0001209191-17-015984 Mar 1, 2017 Feb 27, 2017
8-K ABIO-FORM 8-K EXEC COMPENSATION 0001564590-17-003115 Mar 1, 2017 Feb 27, 2017
4 FORM 4 SUBMISSION 0001209191-17-015978 Mar 1, 2017 Feb 27, 2017
4 FORM 4 SUBMISSION 0001209191-17-015981 Mar 1, 2017 Feb 27, 2017
4 FORM 4 SUBMISSION 0001209191-17-012759 Feb 21, 2017 Feb 16, 2017
4 FORM 4 SUBMISSION 0001209191-17-012760 Feb 21, 2017 Feb 16, 2017
4 FORM 4 SUBMISSION 0001209191-17-012758 Feb 21, 2017 Feb 16, 2017
4 FORM 4 SUBMISSION 0001209191-17-012763 Feb 21, 2017 Feb 16, 2017
8-K ABIO-FORM 8-K EXEC COMPENSATION AND BOARD OPTIONS 0001564590-17-001838 Feb 21, 2017 Feb 16, 2017
3 FORM 3 SUBMISSION 0001209191-17-012750 Feb 21, 2017 Feb 16, 2017
4 FORM 4 SUBMISSION 0001209191-17-012752 Feb 21, 2017 Feb 16, 2017
4 FORM 4 SUBMISSION 0001209191-17-012803 Feb 21, 2017 Feb 16, 2017
4 FORM 4 SUBMISSION 0001209191-17-012755 Feb 21, 2017 Feb 16, 2017
4 FORM 4 SUBMISSION 0001209191-17-012756 Feb 21, 2017 Feb 16, 2017
4 FORM 4 SUBMISSION 0001209191-17-012757 Feb 21, 2017 Feb 16, 2017
SC 13G/A SC 13G/A 0001144204-17-009016 Feb 14, 2017
SC 13G/A SC 13G/A 0001144204-17-009047 Feb 14, 2017
SC 13G/A SC 13G/A 0001104659-17-008446 Feb 13, 2017
8-K 8-K 0001564590-17-000383 Jan 18, 2017
8-K 8-K 0001193125-17-007864 Jan 11, 2017
424B5 424B5 0001193125-17-007870 Jan 11, 2017
10-Q 10-Q 0001564590-16-029259 Nov 14, 2016 Sep 30, 2016
8-K ABIO-8K-20161114 0001564590-16-029274 Nov 14, 2016
4 FORM 4 SUBMISSION 0001209191-16-146208 Oct 18, 2016
8-K ABIO-8K-20161006 0001564590-16-025688 Oct 6, 2016
4 FORM 4 SUBMISSION 0001209191-16-142260 Sep 21, 2016 Sep 20, 2016
4 FORM 4 SUBMISSION 0001209191-16-142261 Sep 21, 2016 Sep 20, 2016
4 FORM 4 SUBMISSION 0001209191-16-142259 Sep 21, 2016 Sep 20, 2016
4 FORM 4 SUBMISSION 0001209191-16-142255 Sep 21, 2016 Sep 19, 2016
CT ORDER 9999999997-16-025752 Sep 14, 2016
8-K 8-K 0001564590-16-024525 Aug 18, 2016
8-K ABIO-8K-20160809 0001564590-16-023706 Aug 9, 2016
10-Q 10-Q 0001564590-16-023718 Aug 9, 2016 Jun 30, 2016
S-8 S-8 0001193125-16-626483 Jun 20, 2016
4 FORM 4 SUBMISSION 0001209191-16-127434 Jun 13, 2016 Jun 9, 2016
4 FORM 4 SUBMISSION 0001209191-16-127436 Jun 13, 2016 Jun 9, 2016
8-K 8-K 0001564590-16-020545 Jun 13, 2016 Jun 9, 2016
4 FORM 4 SUBMISSION 0001209191-16-127438 Jun 13, 2016 Jun 9, 2016
4 FORM 4 SUBMISSION 0001209191-16-127439 Jun 13, 2016 Jun 9, 2016
10-Q 10-Q 0001564590-16-019116 May 11, 2016 Mar 31, 2016
8-K 8-K 0001564590-16-019120 May 11, 2016
DEFA14A DEFA14A 0001193125-16-559633 Apr 27, 2016
DEF 14A DEF 14A 0001193125-16-559626 Apr 27, 2016 Jun 9, 2016
8-K 8-K 0001564590-16-016325 Apr 18, 2016
4 FORM 4 SUBMISSION 0000899243-16-017726 Apr 6, 2016 Apr 4, 2016
4 FORM 4 SUBMISSION 0000899243-16-017728 Apr 6, 2016 Apr 5, 2016
4 FORM 4 SUBMISSION 0000899243-16-017727 Apr 6, 2016 Apr 5, 2016